Procurement Summary
Country: Brazil
Summary: Price Registration for Future Acquisition of Medicines - Legal Demand 16. Protocol Nº 25.856.925-3
Deadline: 07 Jul 2026
Posting Date: 23 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143857583
Document Ref. No.: 90779/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Price registration for future purchase of medicines - legal demand 16. Protocol nº 25.856.925-3 UASG code: 456793 Notice from: 06/23/2026 from 08:00 to 17:59 Proposal Delivery: from 06/23/2026 at 08:00 MEDICINAL EXTRACT, ACTIVE INGREDIENT ESSENTIAL OIL ALPINIA ZERUMBET SYN. A. SPECIOSA, SABINENE CONCENTRATION 17.5 MG, PHARMACEUTICAL FORM SPRAY Quantity: 48 AZELASTINE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH FLUTICASONE, CONCENTRATION 137 MCG/G + 50 MCG/G, PHARMACEUTICAL FORM SUSPENSION SPRAY FOR INHALATION Quantity: 144 BECLOMETHASONE DIPROPIONATE, PRESENTATION ORAL SPRAY, DOSAGE 250MCG/DOSE, ADDITIONAL CHARACTERISTICS DOSING BOTTLE WITH AEROGATOR NOZZLE Quantity: 24 BECLOMETHASONE DIPROPIONATE, CONCENTRATION 50 MCG/DOSE, PHARMACEUTICAL FORM ORAL AEROSOL, ADDITIONAL FEATURE DOSING BOTTLE WITH AEROGATOR NOZZLE Quantity: 24 BECLOMETHASONE DIPROPIONATE, COMPOSITION ASSOCIATED WITH FORMOTEROL FUMARATE, CONCENTRATION 100 MCG + 6 MCG/DOSE, FORM PHARMACEUTICA POWDER FOR ORAL INHALATION, ADDITIONAL FEATURE DOSING BOTTLE WITH AEROGATOR NOZZLE Quantity: 264 BECLOMETHASONE DIPROPIONATE, COMPOSITION ASSOCIATED WITH FORMOTEROL FUMARATE, CONCENTRATION 100 MCG + 6 MCG/DOSE, AEROSOL PHARMACEUTICAL FORM ORAL Quantity: 144 BECLOMETHASONE DIPROPIONATE, COMPOSITION ASSOCIATED WITH FORMOTEROL FUMARATE, CONCENTRATION 200 MCG/DOSE + 6 MCG/DOSE, ORAL AEROSOL PHARMACEUTICAL FORM, ADDITIONAL CHARACTERISTICS WITH INHALER Quantity: 48 BECLOMETHASONE DIPROPIONATE, COMPOSITION ASSOCIATED WITH FORMOTEROL FUMARATE, CONCENTRATION 200 MCG/DOSE + 6 MCG/DOSE, PHARMACEUTICAL FORM POWDER FOR ORAL INHALATION, ADDITIONAL CHARACTERISTICS WITH INHALER Quantity: 24 BETAXOLOL HYCLORHYDRATE, CONCENTRATION 0.5%, SOLUTION PRESENTATION OPHTHALMIC Quantity: 24 BUDESONIDE, NASAL AEROSOL PRESENTATION, CONCENTRATION 50MCG/DOSE, ADDITIONAL CHARACTERISTICS BOTTLE WITH DOSING VALVEbr...
Documents
Tender Notice